Week 11 Haematology Flashcards

(174 cards)

1
Q

how are thrombocytes formed

A

-pluripotent HSC
-common myeloid progenitor
-megakaryoblast
-promegakaryocyte
-thrombocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how are erythrocytes formed

A

-pluripotent HSC
-common myeloid progenitor
-proerythroblast
-basophilic erythrocyte
-polychromatic erythroblast
-orthochromatic erythroblast (normoblast)
-polychromatic erythrocyte (reticulocyte)
-erythrocyte

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how are basophils formed

A

-pluripotent HSC
-common myeloid progenitor
-myeloblast
-B.promyelocyte
-B.myelocyte
-B.metamyelocyte
-B.band
-basophil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how are neutrophils formed

A

-pluripotent HSC
-common myeloid progenitor
-myeloblast
-N.promyelocyte
-N.myelocyte
-N.metamyelocyte
-N.band
-neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how are Eosinophils formed

A

-pluripotent HSC
-common myeloid progenitor
-myeloblast
-E.promyelocyte
-E.myelocyte
-E.metamyelocyte
-E.band
-Eosinophil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how are mast cells formed

A

-pluripotent HSC
-common myeloid progenitor
-mast cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how are macrophages and myeloid dendritic cells formed

A

-pluripotent HSC
-common myeloid progenitor
-myeloblast
-monoblast
-promonocyte
-monocyte
-macrophages and myeloid dendritic cells (3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how are plasma cells formed

A

-pluripotent HSC
-common lymphoid progenitor
-lymphoblast
-prolymphocyte
-small lymphocyte (4)
-T and B lymphocyte
-Plasma cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how are NKC formed

A

-pluripotent HSC
-common lymphoid progenitor
-lymphoblast
-prolymphocyte
-NKC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how are lymphoid dendritic cells formed

A

-pluripotent HSC
-common lymphoid progenitor
-lymphoid dendritic cells (3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

define leukopoiesis

A

the physiological process of white blood cell (leukocyte) formation and maturation within the bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are HSC

A

undifferentiated cells capable of prosecuting all blood cell types

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are common progenitors

A

intermediate cells that give rise to both myeloid and lymphoid cell lineages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are granulocyte/monoctes

A

differentiate into myeloid cells, leading to neutrophils, eosinophils,
basophils, and monocytes/macrophages.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are megakaryocytes/platelets

A

megakaryocytes differentiate into platelets that are essential for clotting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is lymphoid development

A

process that yields lymphocytes, including B and T cells within the lymphoid lineage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is T lymphocyte differentiation

A

specific pathway leading to the development of T cells from lymphoid progenitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

morphology of neutrophils

A

polymorphonuclear with granules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

function of neutrophils

A

phagocytosis of bacteria and fungi in innate immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

location of neutrophils

A

circulate in blood, and migrate to site of infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

lifespan of neutrophils

A

relatively short lifespan (6-8 hours in circulation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

morphology of monocytes

A

kidney shaped nucleus, fine granules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

function of monocytes

A

precursors of tissue macrophages and dendritic cells involved in immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

location of monocytes

A

circulate in blood and migrate to tissues PRN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
lifespan of monocytes
can circulate for a few days before entering tissue and living for weeks to months
26
morphology of macrophages
irregularly shaped nucleus and abundant cytoplasm
27
function of macrophages
phagocytosis of pathogens and debris, antigen presentation, and tissue repair
28
location of macrophages
found in various tissues such as the lung, liver and spleen
29
lifespan of macrophages
long lifespans, from months to years within tissues
30
morphology of eosinophils
bilobed nucleus and large granules
31
function of eosinophils
defence against parasitic infections and involvement in allergies
32
location of eosinophils
found in tissues and the bloodstream especially at sites of inflammation
33
lifespan of eosinophils
relatively short (8-12 hours)
34
define chemotaxis
biological process in which cels, such as immune cells, move in response to chemical signals or gradients
35
define phagocytosis
process by which certain cells, notably phagocytes like neutrophils, macrophages and Dc, engulf and internalise solid particles, such as bacteria, debris or foreign material
36
morphology of T cells
T cells have a round or irregularly shaped nucleus and minimal cytoplasm -several types Tc (CD8+), Th (CD4+), Treg, T memory
37
function of T cells
-cell mediated immunity -recognise and attack infected or abnormal host cells such as virally infected cells or cancer cells
38
location of T cells
-T cells are found in the blood and lymphatic system, but are also in lymphoid organs (spleen, thus, LN) -they move to the site of infection
39
lifespan of T cells
varies, some circulate for weeks and months while memory T cells can circulate for many years
40
morphology of B cells
B cells have a round nucleus and a larger amount of cytoplasm compared to T cells
41
function of B cells
-B cells are responsible for humeral immunity -produce immunoglobulins (anitbodies) that can neutralise pathogens, mark them for detrsution or enhance phagocytosis -B cells also play a role in presenting antigens to T cells
42
location of B cells
-found in lymphoid organs, lymph nodes, the spleen and in the bloodstream, they can also be found in peripheral tissues
43
lifespan of B cells
variable lifespans; some differentiate into short lived plasma cells while others form long living b memory cells
44
define leukocytosis
An abnormal increase in the number of white blood cells (leukocytes) in the blood, often indicative of an immune response to infection or other underlying medical conditions *WBC > 11,000/microL
45
define leukopenia
A decrease in the total white blood cell count in the blood, potentially increasing the risk of infections and impairing the immune system's function.
46
define neutropenia
condition characterized by a deficiency of neutrophils (a type of white blood cell), which can make individuals more susceptible to bacterial infections.
47
define monocytopenia
A reduction in the number of monocytes (a type of white blood cell) in the blood, potentially affecting the body's ability to fight certain infections and inflammatory conditions.
48
define lymphopaenia
A lower-than-normal count of lymphocytes (a type of white blood cell), which can weaken the immune response and increase vulnerability to infections.
49
function of chemokine
subset of cytokines that specifically attract immune cells to sites of infection or inflammation
50
function of cytokines
small signalling proteins produced by immune cells to regulate inflammation, cell communication and immune responses
51
function of mast cells
tissue resident immune cells that release inflammatory mediators like histamine in response to allergens or pathogens, playing a central role in allergic reactions
52
function of NK cells
cytotoxic lymphocytes that recognise and destroy infected cells without prior sensitisation, contributing to early defence against infections and tumour surveillance
53
functions of neutrophil
-phagocytosis: ingest and release into phagosome -degranulation: release granules into extracellular environment -netosis: expulsion of nuclear material in the form of neutrophil extracellular traps (NET)
54
functions of macrophages
-phagocytosis: ingest harmful wastes, pathogens and microbes -inflammation: secrete pro inflammatory cytokines and antimicrobial mediators
55
function of dendritic cells
-antigen capturing : detect PAMP's -antigen presentation: process antigens into smaller peptides for antigen presentation
56
list the steps in pathogen recognition
-pathogen exposure -antigen identification -PRR binding -phagocytosis -antigen presentation -T cell recognition -B cell recognition
57
describe 'pathogen exposure' in pathogen recognition
immune system encounters a pathogen, such as bacterium, virus or fungus through inhalation, digestion other physical contact
58
describe 'antigen identification' in pathogen recognition
immune cells (macrophages, Dc, neutrophils) are equipped with receptors called pattern recognition receptors (PRR) that recognise conserved molecular patterns found on pathogens
59
describe 'PRR binding' in pathogen recognition
when PRR's on immune cells bind to PAMP's on the pathogens surface, this binding activates the immune cell, activation triggers a series of intracellular signalling events, leading to the initiation of the immune response
60
describe 'phagocytosis' in pathogen recognition
phagocytes engulf the pathogen through phagocytosis, internalising pathogens in a vesicle called a phagosome
61
describe 'antigen presentation' in pathogen recognition
dendritic cells capture pathogens and digest them, they then present fragments of the pathogen's antigens on their cells surfaces using MHC molecules
62
describe 'T cell recognition' in pathogen recognition
-Th cells (CD4+) recognise antigen-MHC complexes on Dc -this activates Th cells, which release cytokines that orchestrate immune response -Tc cells (CD8+) can also recognise antigens presented by infected host cells and directly kill them
63
describe 'B cell recognition' in pathogen recognition
-B cells recognise antigens directly, without need for antigen presentation -once activated they produce s+c antibodies to pathogens antigens -pathogen is neutralised or tagged for destruction by antibodies
64
what is the classical complement pathway
C1 recognises immune complexes formed by the binding of IgG or IgM to an antigen.
65
what is the alternative complement pathway
Non-specific activation by bacteria, fungi, and parasites via C3b deposition on the surface of microbes
66
what is the lectin complement pathway
Mannose Binding Lectin (MBL) attaches to the mannose sugar residues on bacterial surfaces
67
what are the actions of complements
opsonisation: complements coat pathogens, making them more susceptible to phagocytosis inflammation: increased blood flow, immune cells, inflammatory mediates to combat infection + promote repair punching holes: create pores in membranes of cells leading to lysis and destruction
68
Describe the process of T cell recognition and activation
-immune cells recognise specific antigens on pathogens -MHC proteins display antigens for T cell recognition -HLA genes code for MHC proteins in humans -antigen presenting cells process and display antigens using MHC molecules -TCR's interact with MHC molecules to recognise antigens -TCR's become activated when their receptors bind to MHC-antigen complexes
69
list the immunoglobulins
IgM IgD IgG IgE IgA
70
what is the IgM antibody
the first antibody produced during an initial immune response, characterised by pentameric structure and potent agglutination properties
71
what is the IgD antibody
primarily found on the surface of B cells, serving as a receptor to initiate B cell activation and maturation
72
what is the IgG antibody
the most abundant antibody class in the blood, providing long-term protection against infections and facilitating immune memory
73
what is the IgE antibody
involved in allergic and hypersensitivity reactions, particularly by triggering mast cells degranulation in response to allergies
74
what is the IgA antibody
predominantly found in the mucosal secretions and plays a crucial role protecting mucosal surfaces from pathogens
75
epitopes are also known as
also known as Antigenic Determinants
76
what is the idiotype
variable region of an immunoglobulin (determines its characteristics and its ability to bind to a specific antigen)
77
what is complementary determining region
Regions within the variable region that actually comes into contact with the epitope on the antigen
78
Features of antigen-antibody complex
-antibodies have specific regions known as CDR's, which are the antibody's variable domain -CDR's are responsible for binding to antigens -works like the lock and key process
79
distinguish between innate and adaptive immunity
*I= non specific vs A= specific and tailored *I=rapid defence vs A=slower defence *I=tolerance to self antigen (mainly works against non self) vs A=distinguish between self and non self *I=pattern recognition only vs A=specific recognition of all possible antigens I=no memory vs A=memory
80
MHC vs HLA
MHC and HLA are both protein complexes that respond to antigens -MHCI and HLA I are for Tc (CD8+) -MHCII and HLA II are for Th (CD4+) and B cells -MHC is for all organisms whereas HLA (human leukocyte agent) is only for humans
81
what is the epitope/antigenic determinant
a specific part of an antigen that is recognized and bound by an antibody or immune cell receptor
82
what are the five key leukaemia
-Acute myeloblastic leukaemia (AML) -Acute lymphoblastic leukaemia (ALL) -Chronic myelogenous leukaemia (CML) -Chronic lymphocytic leukaemia (CLL) -Multiple myeloma (MM)
83
what is acute myeloblastic leukaemia (AML)
fast growing cancer of blood and bone marrow characterised by rapid proliferation of immature myeloid white blood cells
84
what is acute lymphoblastic leukaemia
rapidly progressing cancer of the blood and bone marrow, primarily affecting lymphoid white blood cells and often seen in children
85
what is chronic myelogenuous leukaemia (CML)
slow growing form of leukaemia that originates in myeloid white blood cells, characterised by the presence of Philadelphia chromosome and a chronic phase that can transform into an acute phase
86
what is chronic lymphocytic leukaemia (CLL)
slowly progressing leukaemia primarily affecting lymphocytes, characterised by accumulation of abnormal white blood cells in blood and bone marrow
87
what is multiple myeloma (MM)
cancer of plasma cells in the bone marrow, leading to the overproduction of MAb and weakened bone marrow structure
88
define leukaemia
malignancy characterised by an excess of clonal white blood cells
89
define lymphoma
heterogenous group of malignancies that arise from the clonal proliferation of various cell subsets of lymphocytes at different stages of maturation -generally arise from lymph nodes
90
what are indolent lymphoid malignancies
malignancies that have a slow and relatively non aggressive growth pattern
91
what are aggressive lymphoid malignancies
malignancies that are characterised by faster growth rate and more invasive nature
92
what are acute lymphoid malignancies
lymphoid malignancies that progress rapidly and involve immature or undeveloped cells
93
what are chronic lymphoid malignancies
lymphoid malignancies that progress more slowly and involve mature but abnormal cells
94
pathophysiology of acute leukaemia
HSC--> common myeloid --> myeloblast with reduced differentiability--> Accumulation of immature myeloid cells (myeloblasts) that cannot mature HSC--> common lymphoid--> lymphoblast with increased proliferative ability--> Excessive accumulation of immature lymphoid cells (lymphoblasts) that overpopulate
95
list the clinical features of acute leukaemia
fatigue infection bleeding hepatosplenomegaly lymphadenopathy headache arthalgia skin rashes
96
describe fatigue in acute leukaemia
due to decrease in healthy erythrocytes (bone marrow overcrowded), less oxygen transported and lesser energy levels
97
describe infection in acute leukaemias
due to fewer functional WBC's (bone marrow overcrowded) , body is less able to fight off infection
98
describe bleeding in acute leukaemia
due to increase in platelets (bone marrow overcrowded), results in impaired blood clotting and increased risk of bleeding
99
describe lymphadenopathy in acute leukaemia
Swelling of lymph nodes is a result of the body's response to the abnormal proliferation of leukemia cells that collect in lymph nodes (Note, only painful in infection)
100
describe hepatosplenomegaly in acute leukaemia
enlargement of the liver and spleen occurs due to the infiltration of leukaemic cells in these organs.
101
describe headache in acute leukaemia
experienced due to increased intracranial pressure due to accumulation of leukaemia cells and reduced blood flow
102
describe arthralgia in acute leukaemia
joint pain is a manifestation of leukaemic cell infiltration into the joints, leading to inflammation and discomfort
103
define skin rashes in acute leukaemia
T cell infiltration to the peripheral skin leads to the rashes and erythema
104
pathophysiology of chronic leukaemia
Hematopoietic Stem Cell (HSC) → Common Myeloid Progenitor → Myeloblast → Mature Myeloid Cells with abnormal proliferation and accumulation, especially mature cells like neutrophils, eosinophils, or basophils. These cells are more differentiated compared to acute leukemia but proliferate excessively and don’t function properly. Hematopoietic Stem Cell (HSC) → Common Lymphoid Progenitor → Lymphoblast → Mature Lymphocytes (mostly B-cells) with excessive proliferation and accumulation. These lymphocytes are partially differentiated but still function abnormally and accumulate over time.
105
list the clinical features of chronic leukaemia
fatigue hepatosplenomegaly lymphadenopathy arthralgia
106
describe fatigue in chronic leukaemia
due to a decrease in healthy red blood cells, leading to reduced oxygen transport and energy levels
107
describe hepatosplenomegaly in chronic leukaemia
enlargement of the liver and spleen occurs due to the infiltration of leukaemia cells in these organs
108
describe lymphadenopathy in chronic leukaemia
swelling of lymph nodes is a result of the body's response to the abnormal proliferation of leukaemia cells (only painful in infection)
109
describe arthralgia in chronic leukaemia
joint pain is a manifestation of leukaemia cell infiltration into the joints, leading to inflammation and discomfort
110
list the common complications of haemtological malignancies
organomegaly bleeding/bruising infection anaemia renal failure bone pain
111
describe organomegaly as a complication of haematological malignancies
typically occurs because of the uncontrolled growth and accumulation of cancerous cells within an organ, leading to its enlargement and disruption of normal tissue structure and function
112
describe bleeding/bruising as a complication of haematological malignancies
occurs when malignant tumours invade blood vessels, impairing their integrity, when cancer disrupts the normal clotting process by affecting platelet production or function
113
describe infection as a complication of haematological malignancies
underproduction of immune cells results in a weakened immune system and increased exposure to pathogens such as viruses
114
describe anaemia as a complication of haematological malignancies
Occurs when the abnormal cancerous cells crowd out healthy blood-forming cells in the bone marrow, leading to reduced production of red blood cells
115
describe renal failure as a complication of haematological malignancies
can occur due to the abnormal proteins (eg MAb) produced by cancerous cells, which can clog and damage the filtering units of the kidneys, impairing their function
116
describe bone pain as a complication of haematological malignancies
bone pain in haematological malignancies can result from the infiltration of abnormal cells into the bone marrow and the subsequent disruption of the normal bone structure and function
117
describe the incidence and prevalence of leukaemia
-leukaemia comprises 3.2% of new cancer diagnoses (between 2014 and 2018) -rate of new cases of leukaemia was 14.3 per 10000 men and women over the same time -Acute LL is more common in paediatric population
118
list the risk factors for haematological malignancies
-chemicals/radiation -genetic abnormality -smoking -viruses -past medical history -family history
119
how are chemicals/radiation a risk factor for haematological malignancies
exposure to certain chemicals or ionising radiation can damage DNA, increasing the risk of mutations that can lead to haematological cancers
120
how are genetic abnormality a risk factor for haematological malignancies
people with trisomy 21 (downs syndrome) have an increased risk of haematological cancers due to genetic factors and abnormal immune function
121
how is smoking a risk factor for haematological malignancies
smoking introduces carcinogens into the body, increasing the risk of developing haematological cancers, particularly leukaemia and lymphoma
122
how are viruses a risk factor for haematological malignancies
viruses like Epstein-bar virus can lead to genetic changes in infected cells, increasing the risk of developing haematological cancers Hodgkins lymphoma
123
how is PMHx a risk factor for haematological malignancies
history of certain conditions such as myelodysplastic syndrome (MDS), can increase the risk of progression to more aggressive haematological cancer
124
how is FHx a risk factor for haematological malignancies
FHx of haematological cancers can indicate a genetic predisposition, potentially increasing. an individual's risk of developing these cancers
125
basophil morphology
bi/tri loped nucleus
126
lymphocyte morphology
deep staining, eccentric
127
erythrocyte morphology on stain
darker cells with central pallor (neutrophil are larger with purple nuclei)
128
platelet morphology on stain
small dots
129
what are peripheral blood film
laboratory test in which a drop of blood is spread thinly on a glass slide and then stained to allow for the microscopic examination of blood cells
130
functions of bone marrow biopsy
diagnosis classification staging monitoring treatment guidance
131
what is flow cytometry
-dx tool in haem malignancies -enables analysis of cell surface markers and intracellular proteins on individual cells in blood or bone marrow samples
132
CD34 marker =
indicates immaturity
133
CD19 marker =
Indicative of lymphoid lineage
134
CD117 marker=
Indicative of myeloid lineage
135
what is the Binet staging system
a widely used method for staging chronic lymphocytic leukemia (CLL).
136
stage 1 of Binet staging system for CLL
Patients have fewer than three enlarged lymph node groups and no anaemia or thrombocytopenia
137
stage 2 of Binet staging system for CLL
Patients have three or more enlarged lymph node groups and no anaemia or thrombocytopenia
138
stage 3 of Binet staging system for CLL
Patients have anaemia and/or thrombocytopenia, regardless of number of enlarged lymph node groups
139
Outline use of PCR in haematological malignancies
Identifies specific gene rearrangements, translocations, or mutations (allows to check for genes present in CML, AML and minimal residual disease)
140
Outline use of next generation sequencing in haematological malignancies
Allows for comprehensive sequencing of multiple genes simultaneously/mutations of multiple genes
141
Outline the use of gene profiling in haematological malignancies
Examines expression patterns of genes across a cell population used in lymphomas and leukaemia
142
Outline use of cytogenics for haematological malignancies
Purpose: Detects chromosomal abnormalities in malignant cells eg philadelphia in CML
143
List the phases of leukaemia treatment
induction consolidation maintenance allogenic stem cell transplant
144
induction phase of leukaemia treatment
the primary goal is to rapidly reduce the number of cancer cells in the body using intensive therapy, such as chemotherapy, to induce remission.
145
consolidation phase of leukaemia treatment
Following successful induction, the consolidation phase aims to eliminate any remaining cancer cells and further reduce the risk of relapse, often involving additional chemotherapy or stem cell transplantation
146
maintenance phase of leukaemia treatment
Lower-dose, long-term therapy is administered to prevent the re-emergence of the malignancy, maintaining the patient's remission, and improving their long-term outcomes.
147
allogenic stem cell transplant in leukaemia treatment
A curative option for some haematological malignancies, involving the infusion of healthy stem cells from a donor (typically a family member) to replace the patient's diseased bone marrow, enabling new blood and immune system development
148
Outline the use of MAb in treatment of haematological malignancies
-MAb can be designed to recognise and bind to specific antigens on surface of cancer cells -can be used alone or combined with chemo etc -they work via immune system activation/interference with cell signalling pathways/direct cytoxicity -examples: rituximab for B cell lymphomas and alemtuzumab for CLL
149
Describe the pathophysiology of CML
-reciprocal translocation (chromosome9/chromosome22) forms BCR-ABL fusion gene -BCR-ABL fusion gene codes for active tyrosine kinase -tyrosine kinase initiates uncontrolled cell signalling and proliferation, particularly of granulocytes in the bone marrow and peripheral blood -abnormal accumulation of myeloid cells in the marrow and blood --> fatigue, splenomegaly and leukocytosis
150
What are TKI's
-TKIs, such as imatinib, dasatinib, and nilotinib, work by binding to the active site of the BCR-ABL protein, inhibiting its kinase activity. * By blocking the BCR-ABL kinase, these drugs effectively suppress the aberrant signalling pathways that drive uncontrolled cell proliferation in CML. * Tyrosine kinase inhibitors end in the suffix ‘-inib’.
151
list the common myeloproliferative neoplasms
-polycythaemia vera (PV) -myelofibrosis (MF) -essential thrombocythaemia (ET) -CML
152
what is polycythaemia vera
A rare blood disorder where the bone marrow produces too many red blood cells, white blood cells, and platelets, leading to an increased risk of blood clots and other complications.
153
what is essential thrombocythaemia
A myeloproliferative neoplasm characterized by the overproduction of platelets, potentially resulting in abnormal blood clotting or bleeding.
154
what is myelofibrosis
A myeloproliferative neoplasm in which the bone marrow develops fibrous tissue, impairing its ability to produce normal blood cells and leading to anaemia and an enlarged spleen.
155
outline dx of aplastic anaemia
-involves a complete blood count (CBC) to assess low blood cell counts, as well as a bone marrow biopsy or aspiration to confirm the reduction in hematopoietic (blood-forming) cells in the bone marrow.
156
what is aplastic anaemia
rare and serious blood disorder characterized by a significant reduction in the number of blood cells, including red blood cells, white blood cells, and platelets, in the bone marrow
157
treatment for aplastic anaemia
-blood transfusions, immunosuppressive therapy, bone marrow transplants
158
list the clinical signs of aplastic anaemia
fatigue pallor petechiae infection dyspnoea bleeding dyspnoea headache
159
describe fatigue in aplastic anaemia
Persistent tiredness and weakness due to low red blood cell count, leading to reduced oxygen delivery to tissues.
160
describe pallor in aplastic anaemia
A pale complexion or paleness of the skin and mucous membranes, resulting from decreased red blood cell production.
161
describe petechiae in aplastic anemia
increased susceptibility to bruising and petechiae (small red or purple dots) due to low platelet counts, causing impaired blood clotting
162
describe infection in aplastic anaemia
Weakened immune system because of low white blood cell count, making the body more susceptible to infections.
163
describe dyspnoea in aplastic anaemia
Breathlessness and rapid heart rate, especially during physical activity, due to reduced oxygen-carrying capacity of the blood.
164
describe bleeding in aplastic anaemia
Excessive bleeding from minor cuts, scrapes, or dental procedures due to inadequate platelet function
165
describe headache in aplastic anaemia
Occasional or persistent headaches, which can be a result of anaemia-induced reduced oxygen supply to the brain
166
what are cold sores and their relevance
neuropathic pain, herpes virus resides in the nerves of the mouth or genitals, sores occur when individual is immunosuppressant
167
how to assess splenomegaly on palpation (criteria)
-if able to balot then its the kidney -if able to feel over it then not spleen -if able to feel one notch its the spleen
168
glandular fever/mononucleosis can increase risk of
Hodgkins lymphoma
169
propose of urine protein electrophoresis/bence jones tests
check for MAb/proteins in the urine due to multiple myeloma
170
smudge cells are characteristic of
chronić lymphocytic leukaemia
171
what is PET scan checking for in malignancy
checking for active/functional myeloma lesions in bones and other tissues (in Mutliple myeloma)
172
watch and wait vs active surveillance in haem malignancies
watch and wait- waiting until patient comes back or is worried active surveillance- constant surveillance due to possible for acute disease progression
173
list some broad treatment options for haematological malignancies
-chemotherapy (broader) -immunotherapy (more specific) -radiation therapy (at bone marrow) -bone marrow transplant -full bloods -vaccines (non live) -MAb -long lasting opioids (oxycontin) -screen for other cancers (bowel, prostate, cervical)
174
list some lifestyle advice for haematological malignancies
-avoid sick contacts (risk for febrile neutropenia) -diet -exercise -avoid smoking an alcohol -medicine compliance -mental health support